Analystreport

CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com